Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 0.500% 8/1
-
Market price (% of par)
-
97.22%
-
Total 13F principal
-
$545,532,000
-
Principal change
-
+$11,080,685
-
Total reported market value
-
$530,174,607
-
Number of holders
-
65
-
Value change
-
+$15,090,882
-
Number of buys
-
16
-
Number of sells
-
27
Institutional Holders of INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 as of Q4 2022
As of 31 Dec 2022,
INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 was held by
65 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$545,532,000
in principal (par value) of the bond.
The largest 10 bondholders included
Invesco Ltd., HIGHBRIDGE CAPITAL MANAGEMENT LLC, Calamos Advisors LLC, Aequim Alternative Investments LP, SHENKMAN CAPITAL MANAGEMENT INC, MACKAY SHIELDS LLC, AVIVA PLC, CITIGROUP INC, JPMORGAN CHASE & CO, and Shaolin Capital Management LLC.
This page lists
65
institutional bondholders reporting positions
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.